Barbara Cannon

Ms. Cannon brings over 25 years clinical research experience to NuSirt Sciences. She was responsible for the start-up of ClinTrials Research, one of the early Clinical Research Organizations (CROs), providing outsourced clinical research services to the pharmaceutical industry. She was responsible for initiation of Phase II-IV research activities and participated in the company’s IPO, (NASDAQ:CCRO). Her role as CEO, and Board Director at Celeris Corporation (NASDAQ:CRSC) focused on supporting complex medical device, biologic, and combination FDA product approvals.

Ms. Cannon currently serves on several healthcare and financial services boards and holds an MBA from Northwestern University

Barbara Cannon is the Chief Operating Officer at Nusirt. With a background in Biotechnology, Barbara Cannon has a rich history of leadership and innovation. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.